Julio C. Sartori Valinotti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julio C. Sartori Valinotti has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Julia S. Lehman
Department of Dermatology, Mayo Clinic , Rochester, MN
5 shared publications Surendra Dasari
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
4 shared publications- Aishwarya Ravindran
Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
3 shared publications Alexander Meves
Department of Dermatology Mayo Clinic Rochester Minnesota USA
3 shared publications- Alexander S. Hines
Department of Dermatology, Mayo Clinic, Rochester, Minnesota
3 shared publications Casey A. Gleue
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA
3 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Expert Evaluation of AI-Generated Responses to Hair Loss Questions Across Two Models: Comparative Evaluation Study (Preprint)
BACKGROUND Hair loss is a common dermatologic concern, of which androgenetic alopecia (AGA) and telogen effluvium (TE) are two common etiologies. Accurate diagnosis requires dermatologic examination and histopathology. With barriers to access care, patients are increasingly turning to artificial intelligence (AI). The clinical accuracy of AI remains uncertain. OBJECTIVE Assess AI responses on TE, AGA, and alopecia by board-certified dermatologists. METHODS Two AI foundation models were queried for 43 questions regarding TE, AGA, and hair loss broadly. Four board-certified dermatologists evaluated each response in a blinded manner for accuracy, relevance, appropriateness, word length, and readability (Flesch Kincaid Reading Ease). RESULTS For appropriateness, AI achieved a perfect 5/5 score on the majority of questions. For accuracy and relevance, AI achieved this threshold on the minority of questions. ChatGPT responses were significantly more relevant than Copilot responses overall, and particularly with the general alopecia subset of responses. ChatGPT generated significantly longer responses than Copilot. ChatGPT generated a significant difference in readability and wordcount across the three question topics. CONCLUSIONS AI can generate appropriate responses to hair loss questions, which often lack individualized, evidence-based guidance. AI-generated content should not serve as a substitute for professional dermatologic evaluation. Ongoing clinical oversight of AI-generated medical content is essential to ensure safe and context-appropriate use.
- 2 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessExpert Evaluation of AI-Generated Responses to Hair Loss Questions Across Two Models: Comparative Evaluation Study (Preprint)
BACKGROUND Hair loss is a common dermatologic concern, of which androgenetic alopecia (AGA) and telogen effluvium (TE) are two common etiologies. Accurate diagnosis requires dermatologic examination and histopathology. With barriers to access care, patients are increasingly turning to artificial intelligence (AI). The clinical accuracy of AI remains uncertain. OBJECTIVE Assess AI responses on TE, AGA, and alopecia by board-certified dermatologists. METHODS Two AI foundation models were queried for 43 questions regarding TE, AGA, and hair loss broadly. Four board-certified dermatologists evaluated each response in a blinded manner for accuracy, relevance, appropriateness, word length, and readability (Flesch Kincaid Reading Ease). RESULTS For appropriateness, AI achieved a perfect 5/5 score on the majority of questions. For accuracy and relevance, AI achieved this threshold on the minority of questions. ChatGPT responses were significantly more relevant than Copilot responses overall, and particularly with the general alopecia subset of responses. ChatGPT generated significantly longer responses than Copilot. ChatGPT generated a significant difference in readability and wordcount across the three question topics. CONCLUSIONS AI can generate appropriate responses to hair loss questions, which often lack individualized, evidence-based guidance. AI-generated content should not serve as a substitute for professional dermatologic evaluation. Ongoing clinical oversight of AI-generated medical content is essential to ensure safe and context-appropriate use.
- 22 July 2026
- Published by Wolters Kluwer Health in Journal of Dermatology for Physician Assistants
- Vol. 20 (3) , 14-20
Use of dermoscopy and its association with skin lesion evaluation confidence among PAs in the United States
Introduction: Limited research explores dermoscopy use among physician associates (PAs), outside of one prior study examining dermoscopy in PA student education. This study sought to investigate dermoscopy use among practicing PAs and its impact on their overall diagnostic confidence, including in darker skin tones, when differentiating between benign and malignant skin lesions. Methods: An anonymous survey was developed in 2023 with input from experts in dermoscopy and survey creation to assess PA confidence in skin lesion evaluation as well as PA dermoscopy knowledge and use, perceptions, barriers to use, and prior education. The dermoscopy survey was included as an optional module in the 2024 American Academy of Physician Associates (AAPA) Salary Survey. Results: Of 3,174 invited PAs, 995 (31.4%) responded. Most had never used dermoscopy in practice (81%) but knew or recognized the term (71%). A majority (53%) believed PAs should be trained in dermoscopy during PA school, and 26% reported no interest in future dermoscopy use. Dermatology PAs reported more frequent dermoscopy use and generally greater confidence in evaluating skin lesions, both overall and in darker skin tones, than PAs in other specialties. PAs in surgical (OR=0.2, 95% CI 0.1-0.6) and medical (OR=0.3, 95% CI 0.2-0.5) subspecialties were less likely to use dermoscopy at least annually compared with PAs in primary care. PAs in rural areas were more likely to feel confident in differentiating skin lesions than those in urban areas (OR 2.9, 95% CI 1.7-5.0). Conclusion: Dermoscopy use is associated with higher overall skin lesion assessment confidence. Wider adoption, especially outside dermatology, requires training, increased advocacy, and expanded education.
- 22 July 2026
- Published by Wolters Kluwer Health in Journal of Dermatology for Physician Assistants
- Vol. 20 (3) , 14-20
Use of dermoscopy and its association with skin lesion evaluation confidence among PAs in the United States
Introduction: Limited research explores dermoscopy use among physician associates (PAs), outside of one prior study examining dermoscopy in PA student education. This study sought to investigate dermoscopy use among practicing PAs and its impact on their overall diagnostic confidence, including in darker skin tones, when differentiating between benign and malignant skin lesions. Methods: An anonymous survey was developed in 2023 with input from experts in dermoscopy and survey creation to assess PA confidence in skin lesion evaluation as well as PA dermoscopy knowledge and use, perceptions, barriers to use, and prior education. The dermoscopy survey was included as an optional module in the 2024 American Academy of Physician Associates (AAPA) Salary Survey. Results: Of 3,174 invited PAs, 995 (31.4%) responded. Most had never used dermoscopy in practice (81%) but knew or recognized the term (71%). A majority (53%) believed PAs should be trained in dermoscopy during PA school, and 26% reported no interest in future dermoscopy use. Dermatology PAs reported more frequent dermoscopy use and generally greater confidence in evaluating skin lesions, both overall and in darker skin tones, than PAs in other specialties. PAs in surgical (OR=0.2, 95% CI 0.1-0.6) and medical (OR=0.3, 95% CI 0.2-0.5) subspecialties were less likely to use dermoscopy at least annually compared with PAs in primary care. PAs in rural areas were more likely to feel confident in differentiating skin lesions than those in urban areas (OR 2.9, 95% CI 1.7-5.0). Conclusion: Dermoscopy use is associated with higher overall skin lesion assessment confidence. Wider adoption, especially outside dermatology, requires training, increased advocacy, and expanded education.
- Open Access
- 15 December 2025
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (1) , 100188
Epidemiology of Erdheim-Chester disease in the United States: a SEER-based analysis
- 15 December 2025
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (1) , 100188
Open AccessEpidemiology of Erdheim-Chester disease in the United States: a SEER-based analysis
- Open Access
- 26 November 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (23) , 5988-6000
Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes
Erdheim-Chester disease (ECD) is a rare systemic histiocytic neoplasm, with cardiac morbidities, including cardiovascular (CV) risk factors and cardiac conditions, playing a significant yet poorly understood role in the disease burden. This study evaluated the prevalence, characteristics, and prognosis of ECD in patients with (ECD-C) and without cardiac involvement (ECD-noC) and compared the burden of cardiac morbidities with matched controls. Patients diagnosed with ECD between 1990 and 2021 at a tertiary center were included, with cardiac involvement centrally assessed using radiographic studies. Cardiac morbidities were compared with a control group without ECD, matched for age, sex, body mass index, and smoking history. Among 104 patients with ECD, 39 (37%) had cardiac involvement. Patients with ECD-C had higher rates of hypertension (67% vs 46%), hyperlipidemia (67% vs 40%), heart failure (36% vs 8%), and pericardial effusion (28% vs 2%) than those with ECD-noC. Compared with the matched non-ECD cohort, patients with ECD had higher prevalence of coronary artery disease (20% vs 7%), heart failure (18% vs 4%), and antihypertensive drug use (55% vs 40%). Notably, patients with ECD-C had inferior progression-free survival (PFS) from frontline therapy compared with patients with ECD-noC (5-year PFS, 28.3% vs 70.5%). These findings highlight the burden of CV risk factors and cardiac conditions in ECD, even without a clinical diagnosis of ECD-C. Importantly, this cardiac morbidity burden is substantial for patients with ECD-C compared with ECD-noC. Our findings highlight the need for comprehensive cardiac risk assessment and management strategies to improve patient outcomes.
- 26 November 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (23) , 5988-6000
Open AccessCardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes
Erdheim-Chester disease (ECD) is a rare systemic histiocytic neoplasm, with cardiac morbidities, including cardiovascular (CV) risk factors and cardiac conditions, playing a significant yet poorly understood role in the disease burden. This study evaluated the prevalence, characteristics, and prognosis of ECD in patients with (ECD-C) and without cardiac involvement (ECD-noC) and compared the burden of cardiac morbidities with matched controls. Patients diagnosed with ECD between 1990 and 2021 at a tertiary center were included, with cardiac involvement centrally assessed using radiographic studies. Cardiac morbidities were compared with a control group without ECD, matched for age, sex, body mass index, and smoking history. Among 104 patients with ECD, 39 (37%) had cardiac involvement. Patients with ECD-C had higher rates of hypertension (67% vs 46%), hyperlipidemia (67% vs 40%), heart failure (36% vs 8%), and pericardial effusion (28% vs 2%) than those with ECD-noC. Compared with the matched non-ECD cohort, patients with ECD had higher prevalence of coronary artery disease (20% vs 7%), heart failure (18% vs 4%), and antihypertensive drug use (55% vs 40%). Notably, patients with ECD-C had inferior progression-free survival (PFS) from frontline therapy compared with patients with ECD-noC (5-year PFS, 28.3% vs 70.5%). These findings highlight the burden of CV risk factors and cardiac conditions in ECD, even without a clinical diagnosis of ECD-C. Importantly, this cardiac morbidity burden is substantial for patients with ECD-C compared with ECD-noC. Our findings highlight the need for comprehensive cardiac risk assessment and management strategies to improve patient outcomes.
- Open Access
- 7 March 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 59, 56-58
Subcutaneous nodules accompanied by joint pain and erythema
- 7 March 2025
- Published by Elsevier in JAAD Case Reports
- Vol. 59, 56-58
Open AccessSubcutaneous nodules accompanied by joint pain and erythema
- Open Access
- 24 August 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 52, 153-155
Bilateral inguinal vesicles clustered on an ecchymotic background
- 24 August 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 52, 153-155
Open AccessBilateral inguinal vesicles clustered on an ecchymotic background
- Open Access
- 1 January 2024
- Published by SAGE Publications in Digital Health
- Vol. 10
Teledermatology in practice: Report of Mayo Clinic experience
Background: Delivery of dermatologic care through telemedicine was accelerated by the COVID-19 pandemic. We sought to analyze the teledermatology experience across Mayo Clinic's health care system to identify strengths and limitations of teledermatology. Methods: Electronic health records of dermatology televisits were reviewed from multiple U.S. Mayo Clinic sites from January 2020 through January 2021. Results: A total of 13,181 dermatology televisits were conducted in 6468 unique patients. Patients were primarily female (60.2%), and mean age of all patients was 34.1 years. Synchronous / live video conferencing visits were the most common (40.0%) telecare modality. Synchronous / live audio conferencing and asynchronous / store-and-forward visits comprised 33.0% and 27.0% of appointments. In total, 3944 televisits (29.9%) were successfully concluded via a single appointment. An in-person appointment was needed for 1693 patients (26.2%) after their initial televisit. For patients with a single televisit, synchronous / live video conferencing was the most common virtual modality (58.0% vs 32.2% of patients with multiple visits, p < 0.001). Patients needing in-person follow-up visits were slightly older than those who did not (mean [SD], 38.8 [22.3] vs 35.0 [23.6] years; p < 0.001) but without any sex-based difference. Around one-third of patients needed an in-person follow-up visit after their initial asynchronous / store-and-forward visit which was higher when compared with synchronous / live audio and video conferencing. Conclusion: Single dermatology televisits effectively managed nearly one-third of patients who did not require in-person follow-up. An initial synchronous / live video conferencing was more likely to yield a single clinical encounter, whereas asynchronous / store-and-forward visits required more in-person follow-up. Future studies are required that focus on dermatology-specific cost, diagnoses, access, quality of care, and outcomes.
- 1 January 2024
- Published by SAGE Publications in Digital Health
- Vol. 10
Open AccessTeledermatology in practice: Report of Mayo Clinic experience
Background: Delivery of dermatologic care through telemedicine was accelerated by the COVID-19 pandemic. We sought to analyze the teledermatology experience across Mayo Clinic's health care system to identify strengths and limitations of teledermatology. Methods: Electronic health records of dermatology televisits were reviewed from multiple U.S. Mayo Clinic sites from January 2020 through January 2021. Results: A total of 13,181 dermatology televisits were conducted in 6468 unique patients. Patients were primarily female (60.2%), and mean age of all patients was 34.1 years. Synchronous / live video conferencing visits were the most common (40.0%) telecare modality. Synchronous / live audio conferencing and asynchronous / store-and-forward visits comprised 33.0% and 27.0% of appointments. In total, 3944 televisits (29.9%) were successfully concluded via a single appointment. An in-person appointment was needed for 1693 patients (26.2%) after their initial televisit. For patients with a single televisit, synchronous / live video conferencing was the most common virtual modality (58.0% vs 32.2% of patients with multiple visits, p < 0.001). Patients needing in-person follow-up visits were slightly older than those who did not (mean [SD], 38.8 [22.3] vs 35.0 [23.6] years; p < 0.001) but without any sex-based difference. Around one-third of patients needed an in-person follow-up visit after their initial asynchronous / store-and-forward visit which was higher when compared with synchronous / live audio and video conferencing. Conclusion: Single dermatology televisits effectively managed nearly one-third of patients who did not require in-person follow-up. An initial synchronous / live video conferencing was more likely to yield a single clinical encounter, whereas asynchronous / store-and-forward visits required more in-person follow-up. Future studies are required that focus on dermatology-specific cost, diagnoses, access, quality of care, and outcomes.
- Open Access
- 21 December 2023
- Published by Wiley in JEADV Clinical Practice
- Vol. 3 (2) , 647-652
Value of dermatology hospital conference as a continuing medical education‐accredited activity: A retrospective review
Background: Dermatology grand rounds are popular educational activities among dermatologists and trainees, contributing to improved knowledge and skills. Dermatology hospital conferences at Mayo Clinic Dermatology are separate from dermatology grand rounds in that they focus on inpatient consultations and dermatology admissions.Objectives: This study aimed to determine the types of cases presented during dermatology hospital grand rounds and evaluate the educational value of this continuing medical education (CME)‐accredited activity.Methods: This retrospective study reviewed all inpatient dermatology cases presented during hospital grand rounds at Mayo Clinic Dermatology in Rochester, MN from 2019 to 2022; this study also reviewed the compiled surveys of faculty participants at our institution from 2019 to 2022.Results: A total of 389 cases met the inclusion criteria for analysis. The most common diagnostic category was inflammatory/autoimmune diseases (157 cases, 40%), followed by infection or infestation (73 cases, 19%), drug‐induced eruptions (49 cases, 13%), neoplastic or metastatic diseases (41 cases, 11%), genetic/congenital disorders (21 cases, 5%), depositional/nutritional/metabolic conditions (15 cases, 4%) and wound/traumatic/iatrogenic dermatoses (12 cases, 3%), which were the least common. Most cases were presented for discussion of diagnosis and management (246 cases, 63%), but others focused on the arrival of diagnosis (119 cases, 31%) or management alone (24 cases, 6%). The compiled surveys of faculty participants (n = 50) indicated high satisfaction with dermatology hospital grand rounds, with the majority expressing that evidence‐based research was incorporated and positively impacted their practice. Most respondents indicated that hospital conference participation improved knowledge (97%), competence (64%), clinician performance (54%), patient outcomes (52%) and team performance (50%).Conclusions: The cases presented during these conferences spanned from challenging inflammatory diseases to simple dermatoses, with over 800 literature references reviewed. Dermatology hospital grand rounds provide high value as a CME‐accredited activity for dermatology faculty, even for those without a specific interest in hospital/inpatient dermatology.
- 21 December 2023
- Published by Wiley in JEADV Clinical Practice
- Vol. 3 (2) , 647-652
Open AccessValue of dermatology hospital conference as a continuing medical education‐accredited activity: A retrospective review
Background: Dermatology grand rounds are popular educational activities among dermatologists and trainees, contributing to improved knowledge and skills. Dermatology hospital conferences at Mayo Clinic Dermatology are separate from dermatology grand rounds in that they focus on inpatient consultations and dermatology admissions.Objectives: This study aimed to determine the types of cases presented during dermatology hospital grand rounds and evaluate the educational value of this continuing medical education (CME)‐accredited activity.Methods: This retrospective study reviewed all inpatient dermatology cases presented during hospital grand rounds at Mayo Clinic Dermatology in Rochester, MN from 2019 to 2022; this study also reviewed the compiled surveys of faculty participants at our institution from 2019 to 2022.Results: A total of 389 cases met the inclusion criteria for analysis. The most common diagnostic category was inflammatory/autoimmune diseases (157 cases, 40%), followed by infection or infestation (73 cases, 19%), drug‐induced eruptions (49 cases, 13%), neoplastic or metastatic diseases (41 cases, 11%), genetic/congenital disorders (21 cases, 5%), depositional/nutritional/metabolic conditions (15 cases, 4%) and wound/traumatic/iatrogenic dermatoses (12 cases, 3%), which were the least common. Most cases were presented for discussion of diagnosis and management (246 cases, 63%), but others focused on the arrival of diagnosis (119 cases, 31%) or management alone (24 cases, 6%). The compiled surveys of faculty participants (n = 50) indicated high satisfaction with dermatology hospital grand rounds, with the majority expressing that evidence‐based research was incorporated and positively impacted their practice. Most respondents indicated that hospital conference participation improved knowledge (97%), competence (64%), clinician performance (54%), patient outcomes (52%) and team performance (50%).Conclusions: The cases presented during these conferences spanned from challenging inflammatory diseases to simple dermatoses, with over 800 literature references reviewed. Dermatology hospital grand rounds provide high value as a CME‐accredited activity for dermatology faculty, even for those without a specific interest in hospital/inpatient dermatology.
- 6 December 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 90 (4) , 841-842
Role of thermoregulatory sweat test in the diagnosis of facial flushing: A retrospective case series
- 6 December 2023
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 90 (4) , 841-842
Role of thermoregulatory sweat test in the diagnosis of facial flushing: A retrospective case series